Injective Price

Injective is a Layer-1 blockchain platform designed for building powerful DeFi and Web3 applications. As the native asset of the Injective ecosystem, INJ powers the network and its rapidly growing ecosystem. Key features of INJ include: - Interoperability: Injective is optimized for cross-chain compatibility and seamless integration with other blockchains. - DeFi focus: It provides developers with plug-and-play modules for creating advanced decentralized finance applications. - Fast transactions: Injective offers high throughput and quick finality for efficient DeFi operations. - Robust ecosystem: The Injective ecosystem is expanding rapidly with various DeFi protocols and Web3 projects. As of 2025-07-04, INJ has a market cap of $1.08B and is ranked #84 by market capitalization. The current price of INJ is $11.08, with a 24-hour trading volume of $4.69M. The circulating supply is 97.72M INJ INJ tokens out of a total supply of 100M INJ. Injective was launched in September 2020 and has since gained significant traction in the DeFi space. It was incubated by Binance and is backed by prominent investors like Pantera Capital and Jump Crypto.

Injective was created on September 29, 2020. The project launched its native token INJ on this date, marking the official creation of the cryptocurrency. Since then, Injective has grown to become a prominent player in the Web3 and DeFi space, offering a fast and interoperable Layer-1 blockchain for building decentralized finance applications. As of 2025-07-04, Injective has a market cap of $1.08B and is ranked 84 among all cryptocurrencies. The current price of INJ is $11.08, with a 24-hour trading volume of $4.69M.

The founders of Injective are Eric Chen and Albert Chon. They co-founded Injective Labs, the company behind INJ, in 2018. Eric Chen serves as the CEO while Albert Chon is the CTO. Both have backgrounds in computer science and finance, with experience at major tech companies and financial institutions. They aimed to create a decentralized exchange protocol that could offer high performance and interoperability across multiple blockchains. The INJ token was launched in 2020 through a Binance Launchpad initial exchange offering. Since then, Chen and Chon have continued to lead development of the Injective ecosystem, which has grown to become a prominent layer-1 blockchain for decentralized finance applications.

Injective operates as a Layer-1 blockchain optimized for building decentralized finance (DeFi) and Web3 applications. It utilizes a Proof-of-Stake consensus mechanism and offers interoperability with other blockchain networks. The INJ token serves as the native asset of the Injective ecosystem, powering transactions, governance, and staking on the network. Key features of Injective include: 1. Fast transaction processing and low fees 2. Built-in modules for creating DeFi applications 3. Cross-chain compatibility, especially with Cosmos-based chains 4. On-chain order book for decentralized trading INJ tokens can be used for: - Paying transaction fees - Participating in network governance - Staking to secure the network and earn rewards - Providing liquidity in DeFi protocols As of 2025-07-04, Injective has a market cap of $1.08B and is ranked 84 among all cryptocurrencies. The current price of INJ is $11.08, with a 24-hour trading volume of $4.69M. The circulating supply is 97.72M INJ INJ tokens, out of a total supply of 100M INJ.

Injective is built on a modular blockchain architecture designed for high performance and interoperability. Key technical components include: 1. Tendermint consensus engine for fast finality 2. Cosmos SDK for modular blockchain development 3. Ethereum Virtual Machine (EVM) compatibility layer 4. Custom modules for DeFi functionality like order matching and derivatives 5. Inter-Blockchain Communication (IBC) protocol for cross-chain interoperability 6. WebAssembly (Wasm) smart contract support This architecture allows Injective to achieve high throughput (up to 10,000 TPS), low latency (sub-second finality), and seamless integration with other blockchains and DeFi protocols. The modular design also enables easy upgrades and customization to support new features and use cases in the future.

The future and roadmap of Injective (INJ) look promising. The project aims to continue enhancing its Layer-1 blockchain infrastructure for DeFi and Web3 applications. Key focus areas include: 1. Scalability improvements to increase transaction throughput and reduce fees 2. Expanding cross-chain interoperability with other major networks 3. Launching new DeFi primitives and financial instruments on the platform 4. Growing the developer ecosystem through grants and hackathons 5. Partnerships with traditional finance institutions to bridge TradFi and DeFi By 2026, Injective is expected to have significantly expanded its ecosystem of dApps and users. Price predictions suggest INJ could reach $12.92 by then. Looking further ahead, analysts forecast potential prices of $18.45 by 2027 and $24.17 by 2030 as adoption grows. The team continues to innovate on core protocol upgrades and new features to maintain Injective's competitive edge in the rapidly evolving blockchain space. With its focus on performance, security, and real-world use cases, Injective is well-positioned for long-term growth and mainstream adoption in the coming years.